drugset / Trial / NCT07036458

To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects

NCT07036458

Phase 1 Completed 8 enrolled JW Pharmaceutical
NaSingle-groupOpen-labelOther

Summary

To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects

Timeline

Start
2025-08-22
Primary completion
2025-09-05
Completion
2025-09-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Epaminurad Small molecule Oral

Indications

No indication recorded.